AAAAAA
Results:
1-7
|
Results: 7
Authors:
Schroder, FH
Wildhagen, MF
Citation: Fh. Schroder et Mf. Wildhagen, Screening for prostate cancer: evidence and perspectives, BJU INT, 88(8), 2001, pp. 811
Authors:
Blijenberg, BG
Yurdakul, G
Van Zelst, B
Bangma, CH
Wildhagen, MF
Schroder, FH
Citation: Bg. Blijenberg et al., Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer, BJU INT, 88(6), 2001, pp. 545-550
Authors:
Van der Cruijsen-Koeter, IW
Wildhagen, MF
De Koning, HJ
Schroder, FH
Citation: Iw. Van Der Cruijsen-koeter et al., The value of current diagnostic tests in prostate cancer screening, BJU INT, 88(5), 2001, pp. 458-466
Authors:
Alers, JC
Krijtenburg, PJ
Vis, AN
Hoedemaeker, RF
Wildhagen, MF
Hop, WCJ
van der Kwast, TH
Schroder, FH
Tanke, HJ
van Dekken, H
Citation: Jc. Alers et al., Molecular cytogenetic analysis of prostatic adenocarcinomas from screeningstudies - Early cancers may contain aggressive genetic features, AM J PATH, 158(2), 2001, pp. 399-406
Authors:
Vis, AN
Noordzij, MA
Fitoz, K
Wildhagen, MF
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer, J UROL, 164(6), 2000, pp. 2156-2161
Authors:
Wildhagen, MF
van Os, TAM
Polder, JJ
ten Kate, LP
Habbema, JDF
Citation: Mf. Wildhagen et al., Efficacy of cascade testing for fragile X syndrome, J MED SCREE, 6(2), 1999, pp. 70-76
Authors:
Wildhagen, MF
ten Kate, LP
Habbema, JDF
Citation: Mf. Wildhagen et al., Screening for cystic fibrosis and its evaluation, BR MED B, 54(4), 1998, pp. 857-875
Risultati:
1-7
|